Eris Lifesciences Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA4395110
EBIT3964460
Earning Per Share262928
Expenses7818621,148
Net Profit355406374
Net Profit Margin293022
Operating Profit Margin363833
Profit Before Tax394442405
Dividends Per Share660
Operation Revenue1,2211,3731,696

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Eris Lifesciences is 0 as of 3/4/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212023
Operating Activities235223271375292
Investing Activities-590-5123-323-982
Financing Activities363-221-335-82688
Others00000
Net Cash Flow8-360-30-2

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20203,068.45104.04-2,948.82223.67
2018312.42-884.38502.63-69.33
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Eris Lifesciences is 292 as of 3/4/2024